| For: | Hoyos S, Posada-Moreno P, Guzman-Arango N, Chanci-Drago R, Chavez J, Andrés-Duarte A, Salazar-Ochoa S. Pancreatic neuroendocrine tumors: Are tumors smaller than 2 cm truly indolent? World J Gastrointest Oncol 2024; 16(5): 1756-1762 [PMID: 38764809 DOI: 10.4251/wjgo.v16.i5.1756] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i5/1756.htm |
| Number | Citing Articles |
| 1 |
Omid Salehi, Ponnandai Somasundar, N Joseph Espat, Abdul Saied Calvino, Mohammad Ali, Sasha Lightfoot, Steve Kwon. Well-differentiated grade 1 and 2 nonfunctioning pancreatic neuroendocrine tumor: Consideration of additional factors to aid treatment decision-making. The American Journal of Surgery 2025; 250: 116622 doi: 10.1016/j.amjsurg.2025.116622
|
| 2 |
Go-Won Choi, Inhyuck Lee, Younsoo Seo, Youngmin Han, Yoon Soo Chae, Hye-Sol Jung, Young Jae Cho, Wooil Kwon, Jin-Young Jang, Joon Seong Park. Prognostic and recurrence implications of subdividing WHO grade 2 pancreatic neuroendocrine tumors at a 10% Ki-67 threshold. Pancreatology 2026; 26(2): 265 doi: 10.1016/j.pan.2026.01.079
|
